Business

TR-1: Notifications of Major

TR-1: Notifications of Major.

articleHikma Pharmaceuticals PlcMay 15, 20083/company/hikma-pharmaceuticals-plc/news/tr-1-notifications-of-major
TR-1: Notifications of Major

About this update from Hikma Pharmaceuticals Plc

[{"type":"text","content":"\n RNS Number : 5150U Hikma Pharmaceuticals Plc 15 May 2008  \n \nForm TR-1 with annex. FSA Version 2.1 updated April 2007\n\n\n\n\n\nFor filings with the FSA include the annex\nFor filings with issuer exclude the annex \n\n\n\n\n\n\n\n\n\nTR-1: Notifications of Major Interests in Shares\n\n\n\n\n\n\n\n\n\n\n1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:\n\n\n\nHikma Pharmaceuticals plc\n\n\n\n\n\n2. Reason for notification (yes/no)\n\n\n\n\n\nAn acquisition or disposal of voting rights\n\n\n\nX\n\n\n\n\n\nAn acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached \n\n\n\n\n\n\n\n\nAn event changing the breakdown of voting rights\n\n\n\n\n\n\n\n\nOther (please specify):______________\n\n\n\n\n\n\n\n\n3. Full name of person(s) subject to notification obligation:\n\n\n(a) Mr Samih Darwazah\n\n\n\n\n\n\n4. Full name of shareholder(s) (if different from 3):\n\n\nRaya Bakkar\nMs Maria Freire\nMajda Ali Mishlawi\nMs Ana Simao\nVidacos Nominees Limited\n\n\n\n\n\n\n5. Date of transaction (and date on which the threshold is crossed or reached if different):\n\n\n15 May 2008\n\n\n\n\n\n6. Date on which issuer notified:\n\n\n14 May 2008\n\n\n\n\n\n7. Threshold(s) that is/are crossed or reached:\n\n\n37%\n\n\n\n\n\n \n\n\n\n\n8: Notified Details\n\n\n\n\nA: Voting rights attached to shares\n\n\n\n\n\nClass/type of shares\nIf possible use ISIN code\n\n\nSituation previous to the triggering transaction\n\n\nResulting situation after the triggering transaction\n\n\n\n\nNumber of shares\n\n\n1,875,450\n\n\nNumber of voting rights\n\n1,875,450\n\n\nNumber of shares\n\n\n48,225,541\n\n\nNumber of voting rights\n\n\nPercentage of voting rights\n\n\n\n\n\nDirect\n1,875,450\n\n\n\nIndirect\n46,350,091\n\n\n\nDirect\n1.51%\n\n\n\nIndirect\n37.39%\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nB: Financial Instruments\n\n\n\n\n\nResulting situation after the triggering transaction\n\n\n\n\n\nType of financial instrument\n\n\nExpiration date\n\n\nExercise/ conversion period/date \n\n\nNo. of voting rights that may be acquired (if the instrument exercised/converted)\n\n\nPercentage of voting rights\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\...

More updates from Hikma Pharmaceuticals Plc